Spiro Rombotis - Dec 13, 2021 Form 4/A - Amendment Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
President and CEO, Director
Signature
/s/ Spiro Rombotis
Stock symbol
CYCC
Transactions as of
Dec 13, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/16/2021, 03:16 PM
Date Of Original Report
Dec 15, 2021
Previous filing
Nov 22, 2021
Next filing
Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCC Stock Option (right to buy) Award $0 +190K $0.00 190K Dec 13, 2021 Common Stock 190K $3.45 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
F2 These securities were granted as part of the Issuer's annual compensation review to executive officers.
F3 This Form 4 is being amended to correct a typographical error in the number of shares of Common Stock underlying the options granted to the reporting person on December 13, 2021. 190,000 shares of Common Stock underlie the granted options.